Auckland City Hospital is a public hospital located in Grafton, Auckland, New Zealand. It is the largest hospital in New Zealand, as well as one of the oldest medical facilities in the country. It provides a total of 1,165 beds.

There are 1,165 beds in Auckland City Hospital.

During the past decade, Auckland City Hospital conducted 221 clinical trials. In the 10-year time frame, 221 clinical trials started and 101 clinical trials were completed, i.e. on average, 45.7% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 64 clinical trials were completed. i.e. 81% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Auckland City Hospital" #1 sponsor was "Boston Scientific Corporation" with 18 trials, followed by "Gilead Sciences" with 16 trials sponsored, "Trans Tasman Radiation Oncology Group" with 16 trials sponsored, "BeiGene" with 13 trials sponsored and "Pfizer" with 13 trials sponsored. Other sponsors include 294 different institutions and companies that sponsored additional 186 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auckland City Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 18 trials as a collaborator, "Health Research Council, New Zealand" with 7 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 5 trials as a collaborator and "Cancer Trials Ireland" with 5 trials as a collaborator. Other collaborators include 329 different institutions and companies that were collaborators in the rest 264 trials.

According to Clinical.Site data, the most researched conditions in "Auckland City Hospital" are "Coronary Artery Disease" (28 trials), "Peripheral Arterial Disease" (23 trials), "Ulcerative Colitis" (10 trials), "Breast Cancer" (8 trials) and "Coronary Disease" (7 trials). Many other conditions were trialed in "Auckland City Hospital" in a lesser frequency.

Most popular intervention types in "Auckland City Hospital" are "Drug" (208 trials), "Device" (113 trials), "Other" (33 trials), "Procedure" (26 trials) and "Biological" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (57 trials), "Cisplatin" (8 trials), "Paclitaxel" (7 trials), "Atezolizumab" (6 trials) and "Bevacizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Auckland City Hospital" are 345 trials for "All" genders, 21 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 120 active trials in "Auckland City Hospital". 1 are not yet recruiting, 50 are recruiting, 65 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 196 completed trials in Auckland City Hospital, 1 suspended trials, and 39 terminated clinical trials to date.

Out of the total trials that were conducted in Auckland City Hospital, 24 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 160 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 104 trials that are defined as “Not Applicable".